Latest filing published 28 Nov 2023 for Enfusion, Inc., €9.0M.
Filing timeline
BuySaleInsider track record
Stephen Malherbe: trading record in brief
This profile gathers the share dealings of Stephen Malherbe in Enfusion, Inc. Between 16 February 2023 and 27 November 2023, the trades on record add up to 4 filings.
On the market, this insider has only sold: 2 sales, €19.8M in total.
The newest entry dates from 28 November 2023: an open-market sale of €9.0M, in Enfusion, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Malherbe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$9.8645.6% of flowClass A Common StockSEC:0001104659-23-121705:0
- 1,000,000 sharesClass A Common StockSEC:0001104659-23-086516:0
- 1,000,000 shares@ US$11.3554.4% of flowClass A Common StockSEC:0001104659-23-031176:0
- 1,000,000 sharesClass A Common StockSEC:0001104659-23-023814:0
4 of 4 declarations